FDA Approved: LOVASTATIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lovastatin from Lupin Pharmaceuticals, Inc., under the ANDA program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Lovastatin (Lovastatin)

Snippet

SUPPL AP for LOVASTATIN (LOVASTATIN)